Infection with chronic hepatitis C virus and liver transplantation: A role for interferon therapy before transplantation

Liver Transplantation

Volumn 9, Issue 9, 2003, Pages 905-915

  Thomas, Ryan M ^a   Brems, John J ^a   Guzman Hartman, Grace ^a   Yong, Sherri ^a   Cavaliere, Patricia ^a   Van Thiel, David H ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA2A; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; NAUSEA AND VOMITING; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RECURRENT INFECTION; SEROLOGY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 0042882410     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50166     Document Type: Article

References (18)

1. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26: 62S-65S.
2. Murphy EL, Bryzman S, Williams AE, Co-Chien H. Schreiber GB, Ownby HE, et al. Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996;275: 995-1000.
3. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322.
4. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334: 815-820.
5. Everhart JE, Wei Y, Eng H, Charlton MR, Persing DH, Wiesner RH, et al. Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology 1999;29:1220-1226.
6. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998;28:823-830.
7. Rosen HR, Gretch DR, Oehlke M, Flora KD, Benner KG, Rabkin JM, Corless CL. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation 1998;65:1178-1182.
8. Bizollon T, Ducerf c, Trepo C, Mutimer D. Hepatitis C virus recurrence after liver transplantation. Gut 1999;44:575-578.
9. Samuel D, Feray C. Recurrent hepatitis C after liver transplantation: Clinical and therapeutical issues. J Viral Hepatitis 2000; 7:87-92.
10. Van Thiel DH, Finkel R, Friedlander L, Gavaler JS, Wright HI, Gordon R. The association of IgA deficiency but not IgG or IgM deficiency with a reduced patient and graft survival following liver transplantation. Transplantation 1992;54:269-273.
11. Prieto M, Berenguer M, Rimola A, Loinaz C, Barrios C, Clemente G, et al. Liver transplantation in hepatitis C. A Spanish multi-centre experience. Eur J Gastroenterol Hepatol 1998;10: 771-776.
12. Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 1994;20:24S-27S.
13. Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, et al. Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features. Hepatology 1995;22:1-9.
14. Fried MW, Shiffman M, Sterling RK, Weinstein J, Crippin J, Garcia G, et al. A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: Pretreatment stratification by viral burden and genotype. Am J Gastroenterol 2000;95:3225-3229.
15. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, et al. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. N Engl J Med 1995;332:1457-1462.
16. Idilman R, Colantoni A, De Maria N, Van Thiel DH. Interferon treatment of HCV positive cirrhotic patients. Hepatogastroenterology 1998;45:340-344.
17. Cooksley WG. Interferon treatment of chronic hepatitis C with cirrhosis. J Viral Hepatitis 1997;4(suppl)1:85-88.
18. Idilman R, De Maria N, Colantoni A, Dokmeci A, Van Thiel DH. Interferon treatment of cirrhotic patients with chronic hepatitis C. J Viral Hepatitis 1997;4:81-91.